Long-term enzyme replacement therapy improves neurocognitive functioning and hippocampal synaptic plasticity in immune-tolerant alpha-mannosidosis mice
Alpha-mannosidosis is a glycoproteinosis caused by deficiency of lysosomal acid alpha-mannosidase (LAMAN), which markedly affects neurons of the central nervous system (CNS), and causes pathognomonic intellectual dysfunction in the clinical condition. Cognitive improvement consequently remains a maj...
Main Authors: | Stijn Stroobants, Markus Damme, Ann Van der Jeugd, Ben Vermaercke, Claes Andersson, Jens Fogh, Paul Saftig, Judith Blanz, Rudi D'Hooge |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2017-10-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996117301663 |
Similar Items
-
Alpha-Mannosidosis: Therapeutic Strategies
by: Maria Rachele Ceccarini, et al.
Published: (2018-05-01) -
Intellectual functioning in alpha‐mannosidosis
by: Sara S. Cathey, et al.
Published: (2019-11-01) -
Alpha-mannosidosis in children: analysis of the observations and treatment options
by: A. N. Semyachkina, et al.
Published: (2020-09-01) -
The SPARKLE registry: protocol for an international prospective cohort study in patients with alpha-mannosidosis
by: Julia B. Hennermann, et al.
Published: (2020-09-01) -
Intranasal dexmedetomidine and intravenous ketamine for procedural sedation in a child with alpha-mannosidosis: a magic bullet?
by: Matteo Trevisan, et al.
Published: (2019-09-01)